Your browser doesn't support javascript.
loading
A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases.
Montfort, Anne; Pearce, Oliver; Maniati, Eleni; Vincent, Benjamin G; Bixby, Lisa; Böhm, Steffen; Dowe, Thomas; Wilkes, Edmund H; Chakravarty, Probir; Thompson, Richard; Topping, Joanne; Cutillas, Pedro R; Lockley, Michelle; Serody, Jonathan S; Capasso, Melania; Balkwill, Frances R.
Afiliação
  • Montfort A; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Pearce O; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Maniati E; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Vincent BG; Lineberger Comprehensive Cancer Center, Inflammatory Diseases Institute, Departments of Medicine and Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina.
  • Bixby L; Lineberger Comprehensive Cancer Center, Inflammatory Diseases Institute, Departments of Medicine and Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina.
  • Böhm S; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Dowe T; Medical Oncology, Barts Health NHS Trust, London, UK.
  • Wilkes EH; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Chakravarty P; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Thompson R; Bioinformatics Core, The Francis Crick Institute, London, UK.
  • Topping J; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Cutillas PR; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Lockley M; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Serody JS; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Capasso M; Medical Oncology, Barts Health NHS Trust, London, UK.
  • Balkwill FR; Lineberger Comprehensive Cancer Center, Inflammatory Diseases Institute, Departments of Medicine and Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina.
Clin Cancer Res ; 23(1): 250-262, 2017 Jan 01.
Article em En | MEDLINE | ID: mdl-27354470

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Linfócitos B / Cistadenocarcinoma Seroso Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Linfócitos B / Cistadenocarcinoma Seroso Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article